Lanean...
Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience
OBJECTIVE: Data related to the safety and tolerability of treatments for pediatric type 2 diabetes are limited. The TODAY clinical trial assessed severe adverse events (SAEs) and targeted nonsevere adverse events (AEs) before and after treatment failure, which was the primary outcome (PO). RESEARCH...
Gorde:
| Formatua: | Artigo |
|---|---|
| Hizkuntza: | Inglês |
| Argitaratua: |
American Diabetes Association
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661822/ https://ncbi.nlm.nih.gov/pubmed/23704676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2390 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|